Insurance; health benefit plans; insurance committees; impact analysis; Legislative Service Bureau; Oklahoma Insurance Department; report; effective date.
HB1161 creates a new process for reviewing proposed insurance mandates that would affect health benefit plans in Oklahoma. It defines key terms such as “mandate,” “health benefit plan,” “Bureau” (the Legislative Service Bureau), and “Department” (the Oklahoma Insurance Department), and then authorizes legislative leaders to direct the Bureau to submit certain bills to the Insurance Department for an impact analysis.
Under the bill, when a bill is determined to contain a mandate affecting health benefit plans, the Insurance Department must prepare a written report within 60 days. The report must address social impact, medical efficacy, and financial impact, including effects on public health, the number and demographics of people affected, access to care, evidence supporting the proposed service or treatment, premium impacts, insurer/provider costs, and effects on the stability of the insurance market. The Department may use third-party vendors and consult other state agencies when evaluating impacts on state-funded programs.
The bill also limits the number of referrals to six per fiscal year, split evenly between the House and Senate, unless the Insurance Commissioner approves additional referrals in writing. Once completed, the Legislative Service Bureau must provide the report to the bill author, the committee chair, and post it publicly on the legislative website. The act is set to become effective November 1, 2026.
The bill’s impact is procedural rather than directly substantive: it does not itself impose new insurance coverage requirements, but it creates a formal review mechanism for future legislation that would mandate health benefit plan coverage or administrative changes. This would affect the Legislative Service Bureau, the Oklahoma Insurance Department, legislators considering health insurance mandates, insurers, employers, and potentially state-funded health programs that could bear costs from new coverage requirements.
Overall sentiment appears generally favorable or at least not strongly opposed in the recorded House floor action, where the bill passed 60-24 with no debate noted in the transcript. Earlier committee votes also advanced the measure, though not unanimously, suggesting some concern but enough support to move it forward. The main point of contention is likely the added review layer for mandate bills—especially the limit on referrals and the discretion given to legislative leaders and the Insurance Commissioner—which could be viewed either as a useful fiscal/actuarial safeguard or as a procedural hurdle for health coverage legislation.
HB1161 adds a new statutory section to Title 36 establishing a mandate-review process for legislation affecting health benefit plans. It authorizes the Speaker of the House or President Pro Tempore of the Senate, or their delegates, to refer qualifying bills to the Oklahoma Insurance Department for an impact analysis, and requires the Department to report on social, medical, and financial effects within 60 days. The bill also allows use of third-party actuarial or insurance experts, consultation with other state agencies, a cap of six referrals per fiscal year absent written approval, and public posting of the resulting analysis. It does not change insurance coverage requirements directly, but it may influence how future health insurance mandate bills are drafted, evaluated, and advanced.
The recorded legislative history suggests moderate support with limited public debate. The bill advanced through committee votes and passed the House on third reading by a 60-24 margin, and the floor transcript indicates no debate before passage. That pattern suggests the measure was broadly acceptable to a majority of House members, though not without opposition. The available record does not show detailed Senate consideration in the provided materials.
The likely areas of contention are procedural and institutional rather than policy-specific. Supporters may view the bill as a way to ensure that health insurance mandate proposals are evaluated for public health value, clinical evidence, and cost before enactment. Opponents may object to giving legislative leaders gatekeeping authority over which bills are referred, to the six-referral cap, or to the possibility that the review process could slow or discourage mandate legislation. There may also be concern about the added influence of the Insurance Department and outside vendors in shaping the legislative process.